X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/05/19/2447011/28235/en/Rafael-Pharmaceuticals-Inc-Announces-Corporate-Name-Change-to-Cornerstone-Pharmaceuticals-Inc.html
https://www.globenewswire.com/news-release/2022/01/18/2368484/28235/en/Rafael-Pharmaceuticals-Announces-Ongoing-Successful-Enrollment-and-Opening-of-Additional-Sites-for-Phase-2-Clinical-Trial-of-CPI-613-Devimistat-in-Combination-with-Gemcitabine-and-.html
https://www.globenewswire.com/news-release/2022/01/06/2362450/28235/en/Rafael-Pharmaceuticals-Announces-Successful-Completion-of-Dose-Escalation-with-No-Dose-Limiting-Toxicity-DLT-in-First-Cohort-of-APOLLO-613-Phase-1-2-Clinical-Trial-of-CPI-613-Devim.html
https://www.roi-nj.com/2021/11/23/healthcare/rafael-holdings-realigns-leadership-team-to-support-earlier-stage-pipeline-focus/
https://www.globenewswire.com/news-release/2021/11/11/2332725/28235/en/Rafael-Pharmaceuticals-Announces-First-Patient-Enrolled-in-APOLLO-613-Phase-1-2-Clinical-Trial-of-CPI-613-Devimistat-in-Patients-with-Relapsed-Clear-Cell-Sarcoma.html
https://www.marketwatch.com/story/rafael-pharma-shares-down-75-after-pancreatic-cancer-trial-didn-t-meet-primary-endpoint-271635424625
https://www.globenewswire.com/news-release/2021/10/28/2322715/28235/en/Rafael-Pharmaceuticals-Provides-Update-on-Pivotal-Phase-3-Clinical-Trial-in-Patients-with-Metastatic-Pancreatic-Cancer-and-Interim-Analysis-of-Pivotal-Phase-3-Clinical-Trial-in-Pat.html
https://www.globenewswire.com/news-release/2021/09/27/2303540/28235/en/Rafael-Pharmaceuticals-Announces-APOLLO613-Phase-I-II-Clinical-Trial-of-CPI-613-devimistat-in-Combination-with-Hydroxychloroquine-in-Patients-with-Relapsed-Clear-Cell-Sarcoma-Begin.html
https://www.prnewswire.com/news-releases/rafael-holdings-appoints-patrick-fabbio-as-chief-financial-officer-301376104.html
https://www.globenewswire.com/news-release/2021/08/25/2286471/28235/en/Rafael-Pharmaceuticals-Announces-the-Successful-Completion-of-Phase-1b-Clinical-Trial-and-Initiates-Phase-2-for-CPI-613-devimistat-in-Combination-with-Gemcitabine-and-Cisplatin-in-.html
Market Place
Share 
